Cullinan Oncology Inc Live Stock Price Today, Share Analysis and Chart

Name: Cullinan Oncology Inc: Is Infosys Ltd. worth buying?
Item: Cullinan Oncology Inc
Rating: 2.02183325
Author: Trendlyne DVM scores

about

Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is b...

13.14 -0.81 (-5.81%)

131.34% Gain from 52W Low

296.9K

XNAS Volume

XNAS 13 Mar, 2026 12:31 PM (EDT)

Not Eligible

Expensive Valuation

10.8 / 100

Technically Moderately Bullish

70.0 / 100

No estimates available

Cullinan Oncology Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cullinan Oncology Inc Live Stock Price Today, Share Analysis and Chart

Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is b...

131.34% Gain from 52W Low

SWOT Analysis

Cullinan Oncology Inc Live Price Chart